Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse (Q45885673)

17 December 2017

title

Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse (English)

1 reference

17 December 2017

author name string

M Takanashi

1

1 reference

17 December 2017

K Oikawa

2

1 reference

17 December 2017

K Sudo

3

1 reference

17 December 2017

M Tanaka

4

1 reference

17 December 2017

K Fujita

5

1 reference

17 December 2017

A Ishikawa

6

1 reference

17 December 2017

S Nakae

7

1 reference

17 December 2017

R L Kaspar

8

1 reference

17 December 2017

M Matsuzaki

9

1 reference

17 December 2017

M Kudo

10

1 reference

17 December 2017

M Kuroda

11

1 reference

17 December 2017

publication date

28 May 2009

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

16

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

982-989

1 reference

17 December 2017

Knocking down disease with siRNAs

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

RNA interference in adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

RNAi-mediated gene silencing in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Transvascular delivery of small interfering RNA to the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Treatment with siRNA and antisense oligonucleotides targeted to HIF-1alpha induced apoptosis in human tongue squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Inhibition of respiratory viruses by nasally administered siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Advances in skin gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Cutaneous gene transfer for skin and systemic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Expression of naked DNA in human, pig, and mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

A direct in vivo approach for skin gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

The immunology of Eta-1/osteopontin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Role of osteopontin in amplification and perpetuation of rheumatoid synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

The skin: its structure and response to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

MicroRNA expression in zebrafish embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Delivery and inhibition of reporter genes by small interfering RNAs in a mouse skin model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Topical matrix-based siRNA silences local gene expression in a murine wound model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Osteopontin small interfering RNA protects mice from fulminant hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

inferred from DOI database lookup

7 January 2021

based on heuristic

Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.66

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2009.66

1 reference

17 December 2017

Dimensions Publication ID

1009474255

0 references

1 reference

17 December 2017